Table 4.
Clinical outcomes 0-48 months
| Outcome (range) | Age years | N |
0 months |
48 months |
0-48 month difference* |
SRM | |
|---|---|---|---|---|---|---|---|
| Mean (95%-CI) | Mean (95%-CI) | Mean (95%-CI) | P-value | ||||
|
All diagnoses | |||||||
| Symptom Score (0-10) | |||||||
| -All patients |
1-75 |
1501 |
6.09 (6.00-6.18) |
3.26 (3.14-3.37) |
2.83 (2.71-2.96) |
<0.001 |
1.13 |
| -Adults |
17-75 |
1067 |
6.07 (5.96-6.17) |
3.41 (3.27-3.54) |
2.66 (2.51-2.81) |
<0.001 |
1.09 |
| -Children |
1-16 |
434 |
6.15 (5.98-6.32) |
2.90 (2.68-3.11) |
3.25 (3.01-3.50) |
<0.001 |
1.25 |
| -Art therapy |
1-75 |
273 |
6.19 (6.00-6.38) |
3.24 (2.98-3.50) |
2.95 (2.68-3.23) |
<0.001 |
1.28 |
| -Eurythmy therapy |
1-75 |
791 |
6.23 (6.10-6.36) |
3.35 (3.18-3.51) |
2.88 (2.70-3.06) |
<0.001 |
1.12 |
| -Rhythmical massage Therapy |
1-75 |
146 |
6.06 (5.78-6.33) |
3.56 (3.16-3.96) |
2.50 (2.08-2.91) |
<0.001 |
0.98 |
| -Medical therapy |
1-75 |
291 |
5.63 (5.43-5.84) |
2.88 (2.62-3.14) |
2.75 (2.47-3.04) |
<0.001 |
1.12 |
| First ranked symptom (0-10) |
1-75 |
1491 |
6.42 (6.32-6.52) |
3.29 (3.29-3.42) |
3.13 (2.99-3.28) |
<0.001 |
1.09 |
| CES-D (0-60) |
17-75 |
849 |
21.83 (21.02-22.64) |
15.34 (14.55-16.13) |
6.49 (5.72-7.27) |
<0.001 |
0.56 |
| SF-36 Physical Component |
17-75 |
1043 |
42.98 (42.33-43.68) |
46.67 (46.01-47.33) |
3.69 (3.11-4.27) |
<0.001 |
0.39 |
| SF-36 Mental Component |
17-75 |
1043 |
37.90 (37.14-38.66) |
45.41 (44.69-46.13) |
7.51 (6.75-8.26) |
<0.001 |
0.60 |
| SF-36 scales (0-100) | |||||||
| -Physical Function |
17-75 |
1069 |
74.70 (73.28-76.13) |
80.30 (78.84-81.76) |
5.60 (4.38-6.82) |
<0.001 |
0.28 |
| -Role Physical |
17-75 |
1063 |
44.75 (42.38-47.12) |
66.35 (63.95-68.74) |
21.60 (19.03-24.17) |
<0.001 |
0.51 |
| -Role Emotional |
17-75 |
1059 |
49.32 (46.79-51.86) |
70.46 (68.08-72.84) |
21.14 (18.44-23.84) |
<0.001 |
0.47 |
| -Social Functioning |
17-75 |
1072 |
59.17 (57.57-60.76) |
74.95 (73.43-76.47) |
15.79 (14.12-17.46) |
<0.001 |
0.57 |
| -Mental Health |
17-75 |
1070 |
53.62 (52.44-54.80) |
65.32 (64.12-66.52) |
11.70 (10.54-12.86) |
<0.001 |
0.60 |
| -Bodily Pain |
17-75 |
1070 |
54.19 (52.47-55.91) |
67.70 (66.01-69.38) |
13.51 (11.84-15.17) |
<0.001 |
0.49 |
| -Vitality |
17-75 |
1070 |
38.05 (36.93-39.18) |
51.72 (50.48-52.97) |
13.67 (12.41-14.92) |
<0.001 |
0.65 |
| -General Health |
17-75 |
1061 |
50.22 (49.04-51.39) |
59.12 (57.80-60.45) |
8.91 (7.76-10.06) |
<0.001 |
0.47 |
|
Diagnosis groups | |||||||
| ADHD: FBB-HKS Total (0-3) |
3-16 |
60 |
1.74 (1.61-1.87) |
1.25 (1.08-1.41) |
0.49 (0.34-0.64) |
<0.001 |
0.85 |
| Anxiety Severity (0-10) |
17-75 |
61 |
7.08 (6.61-7.55) |
3.72 (2.99-4.45) |
3.36 (2.67-4.06) |
<0.001 |
1.24 |
| Asthma Severity (0-10) |
2-70 |
88 |
5.50 (5.04-5.96) |
3.11 (2.59-3.64) |
2.39 (1.86-2.91) |
<0.001 |
0.96 |
| Migraine Severity (0-10) |
17-75 |
44 |
6.77 (6.23-7.32) |
4.18 (3.34-5.02) |
2.59 (1.84-3.34) |
<0.001 |
1.05 |
| Depression: CES-D (0-60) |
17-70 |
133 |
34.93 (33.58-36.27) |
19.75 (17.58-21.92) |
15.18 (12.94-17.41) |
<0.001 |
1.16 |
| Low back pain: HFAQ (0-100) |
17-75 |
73 |
62.13 (57.54-66.72) |
75.71 (71.48-79.95 |
13.59 (9.83-17.34) |
<0.001 |
0.84 |
| Low back pain: LBPRS (0-100) | 17-75 | 72 | 36.61 (32.75-40.46) | 27.69 (23.37-32.01) | 8.92 (5.11-12.73) | <0.001 | 0.55 |
Patients with available baseline values, last value carried forward. CI Confidence interval. *Positive differences indicate improvement. SRM Standardised Response Mean effect size (minimal: < 0.20, small: 0.20-0.49, medium: 0.50-0.79, large: ≥0.80). CES-D Center for Epidemiological Studies Depression Scale, German version [34,35], ADHD Attention Deficit Hyperactivity Symptoms, FBB-HKS Total Fremdbeurteilungsbogen für Hyperkinetische Störungen (parents’ questionnaire for ADHD core symptoms), Total score [53,54]), HFAQ Hanover Functional Ability Questionnaire [51], LBPRS Low Back Pain Rating Scale Pain Score [52].